Wednesday, July 8, 2026

Rideshare Assault and Pharma Claims Lead Daily Multidistrict Filings

Rideshare safety and pharmaceutical product liability dockets drove a 68-filing surge, led by a substantial influx of cases in the Uber Passenger Sexual Assault Litigation (MDL 3084). Out of 17 new complaints filed in the Uber litigation, Cutter Law PC accounted for 12, while Chaffin Luhana LLP contributed three. A similar high-volume pattern defined the Depo-Provera Litigation (MDL 3140), where Coby Wooten PC and MCH Law PLLC propelled 15 new filings as the litigation continues to expand. Meanwhile, the Hair Relaxer Litigation (MDL 3060) recorded 13 new claims, fueled by six filings from Singleton Schreiber LLP and three from Johnson Law Group. Rounding out the active venues, Wagstaff Law Firm and Levin Papantonio led the Talcum Powder Litigation (MDL 2738) with five new filings, while Wagstaff Law Firm and Friedman Rubin & White spearheaded three new complaints in the Roundup Litigation (MDL 2741). See the full filing feed and firm-level breakdowns here.

Ohio Gaming Commission Moves to Ban Credit Cards for Sports Betting

On 2026-07-08, the Ohio Casino Control Commission advanced a major regulatory amendment designed to prohibit the use of credit cards for funding online sports wagering accounts. The proposed ban aims to strengthen responsible gaming protections by preventing consumers from betting with borrowed funds, which regulators argue heightens the risk of financial distress and gambling addiction. Under the new administrative rules, operators would still be permitted to accept other deposit methods, including debit cards, bank transfers, and electronic checks. While the gaming commission is finalizing the rule, the measure must still clear reviews by the state's Common Sense Initiative and the Joint Committee on Agency Rule Review before it can be officially implemented. If approved, Ohio will join a small but growing cohort of states enacting strict banking restrictions to curb sports betting abuse.

First Federal NEC Baby Formula Bellwether Trial Begins in Illinois

The first federal bellwether trial in the preterm infant formula multidistrict litigation commenced on July 6, 2026, in the Northern District of Illinois. Presided over by Chief Judge Rebecca R. Pallmeyer, the trial in Inman v. Mead Johnson & Company, LLC, et al. focuses on allegations that the company's cow's milk-based Enfamil formula increases the risk of necrotizing enterocolitis in premature infants. Plaintiffs in the NEC Litigation (MDL 3026) contend that manufacturers failed to warn parents and healthcare providers about these gastrointestinal risks, while the defense maintains that the products are medically necessary. A second federal bellwether trial, Kelton v. Abbott Laboratories, is currently scheduled to begin on August 10, 2026. The outcomes of these initial federal trials are expected to heavily influence the resolution posture of more than 800 cases currently pending in the litigation.